| Literature DB >> 12495451 |
Jordi Sunyer1, Carmen Herrero, Dolores Ozalla, Maria Sala, Núria Ribas-Fitó, Joan Grimalt, Xavier Basagaña.
Abstract
BACKGROUND: Porphyria cutanea tarda (PCT) is caused by hexachlorobenzene (HCB) in several species of laboratory mammals, but the human evidence is contradictory. In a study among adults of a population highly exposed to HCB (Flix, Catalonia, Spain), the prevalence of PCT was not increased. We aimed at analysing the association of individual urinary porphyrins with the serum concentrations of HCB and other organochlorine compounds in this highly exposed population.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12495451 PMCID: PMC131010 DOI: 10.1186/1476-069x-1-1
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
Characteristics of the 241 subjects
| Variable | n (%) |
| Male | 180 (75) |
| Age | |
| < 45 years | 89 (37) |
| 45–64 years | 84 (35) |
| > 64 years | 68 (28) |
| Alcohol | |
| No | 73 (30) |
| Occasional | 61 (25) |
| Habitual (> 3 drinks a week) | 107 (45) |
| Smoking | |
| Never | 73 (30) |
| Occasional | 11 (5) |
| Ex | 82 (34) |
| Current | 75 (31) |
| <20 cigs./day | 33 (13) |
| ≥ 20 cigs./day | 42 (18) |
| Years living in Flix | |
| 1–9 | 4 (2) |
| 10–19 | 19 (8) |
| >20 | 218 (90) |
Distribution of urinary uroporphyrines (μmol/L) and serum concentrations of organochlorinated compounds (ng/mL) (n = 241 subjects)
| % detectable | Percentiles among detectables | |||||
| Min | p25 | p50 | p75 | Max | ||
| Total porphyrins | 100% | 13.0 | 63.8 | 98.5 | 157 | 497 |
| Uro I | 36% | 2.0 | 6.0 | 10.0 | 16.0 | 37.0 |
| Uro III | 2% | 1.0 | 1.0 | 1.0 | 8.0 | 8.0 |
| Hepta I | 1% | 2.0 | 2.0 | 2.5 | 3.0 | 3.0 |
| Hepta III | 6% | 2.0 | 2.8 | 4.0 | 6.8 | 13.0 |
| Copro I | 76% | 1.0 | 4.0 | 7.0 | 14.0 | 134 |
| Copro III | 86% | 2.0 | 10.0 | 21.5 | 37.0 | 154 |
| HCB | 100% | 2.30 | 13.2 | 21.7 | 37.9 | 1616 |
| DDE | 97% | 0.1 | 2.59 | 6.15 | 14.4 | 67.4 |
| Total PCBs† | 94% | 0.2 | 1.89 | 3.78 | 7.02 | 143 |
| CB-138 | 87% | 0.1 | 0.58 | 1.03 | 1.85 | 35.0 |
| CB-153 | 85% | 0.1 | 0.67 | 1.18 | 2.32 | 40.9 |
| CB-180 | 89% | 0.1 | 0.58 | 1.43 | 2.66 | 63.5 |
Uro: uroporphyrins; Hepta: heptaporphyrins; Copro: coproporphyrins. † PCBs = Σ (28, 52, 101, 118, 138, 153, 180) congeners
Association between urinary porphyrine concentrsations and the study variables (age, sex, alcohol, smoking, years of residence, and organochlorintaed compounds in serum).
| TP | Copro I | Copro III | Uro I + UroIII | |||
| Median (25%–75%) | Detectables n (%) | Median (25%-75%) † | Detectables n (%) | Median (25%-75%) † | Detectables n (%) | |
| Age | ||||||
| <45 | 117 (73–185) | 70 (79) | 7 (3–15) | 85 (96) | 29 (11–46) | 31 (35) |
| 45–64 | 89 (62–132) | 62 (74) | 4 (0.5–8) | 67 (80) | 14 (4.5–27.5) | 24 (29) |
| >64 | 83 (56–126)* | 51 (75) | 4 (1.3–9)* | 56 (82)* | 12.5 (3–30)* | 27 (40) |
| Sex | ||||||
| Female | 85 (62–112) | 42 (69) | 5 (0.5–11) | 60 (98) | 20 (10–31) | 17 (28) |
| Male | 107 (65–165)* | 141 (78) | 5 (2–11) | 148 (82)* | 19 (5–37) | 65 (36) |
| Alcohol | ||||||
| No | 99 (62–144) | 52 (71) | 5 (0.5–11) | 67 (92) | 18 (6–35) | 23 (32) |
| Ocasional | 86 (64–143) | 45 (74) | 5 (0.5–10) | 52 (85) | 19 (7–35) | 21 (34) |
| Habitual | 103 (66–162) | 86 (80) | 5 (3–12) | 89 (83) | 20 (5–35) | 38 (36) |
| Smoking | ||||||
| Never | 86 (62–124) | 52 (71) | 5 (0.5–10) | 64 (88) | 19 (6–29) | 19 (26) |
| Ocasional + Ex | 92 (60–146) | 65 (70) | 4 (0.5–10) | 76 (82) | 12 (4–35) | 33 (35) |
| < 20 cigs./day | 103 (83–159) | 30 (91) | 6 (4–9) | 28 (85) | 20 (7–39) | 12 (36) |
| ≥ 20 cigs./day | 127 (81–588)* | 36 (86)* | 6.5 (3.5–15) | 40 (95) | 32 (12–46)* | 18 (43) |
| Years living in Flix | ||||||
| ≤ 20 years | 165 (86, 240) | 21 (91) | 7 (3, 19) | 22 (95) | 27 (17,51) | 10 (43) |
| > 20 years | 94 (62, 143)* | 162 (74) | 5 (0.5, 10)* | 186 (85) | 19 (6, 34)* | 72 (33) |
| HCB ng/ml (tertiles) | ||||||
| <16.1 | 129 (81–176) | 60 (77) | 7 (2–15) | 73 (94) | 26 (8–43) | 29 (37) |
| 16.1–29.5 | 82 (55–126) | 62 (75) | 4 (0.5–10) | 70 (84) | 18 (5–31) | 28 (34) |
| >29.5 | 92 (64–130)* | 61 (76) | 5 (2–8.5)* | 65 (81)* | 14 (5–31.5)* | 25 (31) |
| DDE ng/ml (tertiles) | ||||||
| < 3.22 | 124 (74–179) | 62 (78) | 7 (2–15) | 74 (94) | 26 (7–49) | 31 (39) |
| 3.22 – 9.88 | 105 (65–161) | 60 (75) | 4 (0.5–10) | 64 (80) | 20 (4.5–35) | 22 (28) |
| > 9.88 | 82 (57–117)* | 61 (74) | 5 (2–8.5)* | 70 (85) | 12 (5–26)* | 29 (35) |
| PCBs ng/ml (tertiles) | ||||||
| < 2.08 | 108 (74, 166) | 63 (80) | 6 (2–13) | 72 (91) | 22 (7, 35) | 21 (27) |
| 2.08–4.89 | 99 (61, 172) | 60 (77) | 4 (2–12) | 69 (88) | 20 (6, 38) | 30 (38) |
| > 4.89 | 87 (59, 130)* | 60 (73) | 4.5 (0.5–9) | 67 (80)* | 13.5 (4, 30)* | 31 (37) |
| CB-138 (tertiles) | ||||||
| < 0.55 | 108 (73–116) | 63 (79) | 5.5 (2.5–13) | 73 (91) | 20 (7.5–36.5) | 19 (24) |
| 0.55 – 1.29 | 99 (61–146) | 63 (80) | 5 (2–12) | 69 (87) | 21 (6–38) | 36 (46) |
| > 1.29 | 89 (60–130)* | 57 (70) | 4 (0.5–9) | 66 (80)* | 13 (4–29)* | 27 (33) |
| CB-153 (tertiles) | ||||||
| < 0.61 | 109 (73–161) | 65 (81) | 6 (3–13.5) | 74 (93) | 21 (8.5–35) | 21 (26) |
| 0.61 – 1.36 | 98 (61–173) | 58 (73) | 4 (0.5–11) | 66 (84) | 20 (5–39) | 30 (38) |
| > 1.36 | 87 (61–130) | 60 (73) | 4 (0.5–9)* | 68 (83) | 13 (5–32) | 31 (38) |
| CB-180 (tertiles) | ||||||
| < 0.61 | 110 (73–168) | 64 (80) | 5 (2–11.5) | 72 (90) | 21 (7–38.5) | 22 (28) |
| 0.61 – 1.80 | 94 (61–143) | 59 (75) | 5 (0.5–12) | 73 (92) | 20 (6–37) | 26 (33) |
| > 1.80 | 90 (60–141)* | 60 (73) | 4.5 (0.5–10) | 63 (77)* | 14 (3–29)* | 34 (41) |
TP: total porphyrins; CPI, CPIII: coproporphyrins I, III; UPI, UPIII: uroporphyrins I, III. * p < 0.05 using the extension of the non-parametric Wilcoxon test for linear trend † non-detectable values were set at the median value between 0 and the detectable level
Adjusted association between urinary porhyrin levels and serum concentrations of organochlorinated compounds (n = 241).
| Organochlorinated compound | TP | Copro I | Copro III |
| Coefficient (se)† | |||
| Single pollutant model | |||
| HCB | -0.265 (0.078)* | -0.321 (0.171) | -0.395 (0.187)* |
| DDE | -0.024 (0.049) | 0.048 (0.115) | -0.051 (0.123) |
| PCBs | -0.005 (0.048) | -0.039 (0.111) | -0.019 (0.120) |
| Multipollutant model†† | |||
| HCB | -0.281 (0.079)* | -0.315 (0.174) | -0.420 (0.190)* |
| DDE | -0.056 (0.053) | 0.039 (0.127) | -0.092 (0.137) |
| PCBs | 0.005 (0.052) | -0.059 (0.121) | -0.011 (0.131) |
TP: Total porphyrins. CPI and CPIII: coproporphyrins, I and III, respectively. † The coefficient gives the relative change in prophyrin levels for a 10-fold concentration increase in the organochlorinated compound., adjusted for age, smoking, alcohol, years of residence in Flix, and creatinine in serum. †† Adjusted for age, smoking, alcohol and years of residence in Flix, as well as for the other organochlorinated compounds in the table. * p < 0.05
Studies on urinary porphyrins in human populations exposed to moderate levels of hexachlorobenzene (HCB).
| Porphyrins | ||||||
| Author year/country (ref) | N | Period | Serum-HCB (range in ng/mL) | UP | CP | Comments |
| WORKERS | ||||||
| Morley 1973/Australia [ | 54 | 1950's-60's | NA | NS | NS | only 1 worker with high UP |
| Burns 1974/USA [ | 20 | 1973–74 | <1–310 | NS | NS | - |
| Currier 1980/USA [ | 50 | 1974–7 | 3–1121 | NS | ↓ | ↓ CP if HCB > 200 |
| Selden 1999/Sweden [ | 27 | 1980's | NA(9E/18NE) | NS | ↑ | ↑ CPIII in E vs NE |
| GENERAL POPULATION | ||||||
| NEONATES | ||||||
| Ozalla 2002/Spain [ | 68 | 1997–99 | 0.4–21 | NS | ↓ | ↓ CPI and CPIII |
| ADULTS | ||||||
| Burns 1975/USA [ | 120 | 1972 | 0–23 | NS | ↑ | - |
| This study/Spain | 242 | 1994 | 2–1616 | NS | ↓ | ↓ CPI and CPIII |
NA: not available. NS: no statistically significant difference. UP: uroporphyrins. CP, CPI and CPIII: coproporphyrins total, I and III. E/NE: number of subjects exposed/non-exposed